Filing Details
- Accession Number:
- 0001140361-10-011609
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-12 12:00:00
- Reporting Period:
- 2010-03-10
- Filing Date:
- 2010-03-12
- Accepted Time:
- 2010-03-12 16:29:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1037760 | Cepheid | CPHD | Laboratory Analytical Instruments (3826) | 770441625 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1318763 | Robert Koska | C/O Cepheid 904 Caribbean Drive Sunnyvale CA 94089 | Svp Ww Commercial Ops | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-03-10 | 30,000 | $9.08 | 37,500 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-03-10 | 30,000 | $19.07 | 7,500 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2010-03-10 | 48,750 | $9.11 | 56,250 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-03-10 | 48,750 | $19.11 | 7,500 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2010-03-10 | 30,000 | $0.00 | 30,000 | $9.08 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2010-03-10 | 48,750 | $0.00 | 48,750 | $9.11 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
15,000 | 2015-04-27 | No | 4 | M | Direct | |
11,250 | 2016-04-26 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 28, 2009.
- The shares vest and are exercisable in equal monthly installments over the 48-month period commencing on January 1, 2007.
- 25% of the shares subject to the grant vested and became exercisable on April 26, 2007 and 2.0833% of the shares vest and are exercisable on each monthly anniversary of the First Vesting Date until 100% vested.